ALXO

Alx Oncology Holdings Inc

• TipRanks·03/24 02:04

  ALX Oncology CEO Makes Notable Move With Latest Stock Sale

• Dow Jones·03/19 13:12

  ALX Oncology Price Target Announced at $5.00/Share by Wells Fargo

• Reuters·03/19 10:37

  ALX ONCOLOGY HOLDINGS, INC. <ALXO.O>: WELLS FARGO INITIATES COVERAGE WITH OVERWEIGHT RATING AND TARGET PRICE $5

• TipRanks·03/19 09:55

  ALX Oncology initiated with an Overweight at Wells Fargo

• Reuters·03/19 06:52

  U.S. RESEARCH ROUNDUP-Carnival, Five Below, McKesson

• NASDAQ·03/13 12:23

  RARE's DTX301 Meets First Key Goal in Phase III OTC Deficiency Study

• NASDAQ·03/12 17:05

  RLMD Stock Surges 42% in a Week: Here's What You Should Know

• TipRanks·03/11 06:00

  Alx Oncology Faces Renewed Nasdaq Listing Risk After Prior Minimum Bid Price Violation

• Dow Jones·03/10 11:48

  ALX Oncology Price Target Maintained With a $4.00/Share by HC Wainwright & Co.

• Benzinga·03/10 11:38

  HC Wainwright & Co. Reiterates Buy on ALX Oncology Holdings, Maintains $4 Price Target

• TipRanks·03/10 10:10

  ALX Oncology price target raised to $4 from $2 at H.C. Wainwright

• TipRanks·03/08 00:12

  Alx Oncology Earnings Call Highlights Biomarker Momentum

• TipRanks·03/06 13:25

  ALX Oncology initiated with a Buy at UBS

• Reuters·03/05 21:01

  ALX Oncology Holdings Inc. Files Initial Beneficial Ownership Statement for Chief Medical Officer Barbara Klencke

• NASDAQ·03/05 10:07

  ACAD Plans Re-Examination After CHMP Rejects Rett Syndrome Drug in EU (Revised)